ROY BOOK: Open Payments
NPI 1245437631 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,486 in 61 payments from 19 companies in 2025. Trend: 2023 $475 · 2024 $1,540 · 2025 $1,486
Food & beverage: $1,458Education: $27
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $347 |
| Axsome Therapeutics, Inc. | 6 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $112 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Lundbeck LLC | 4 | $103 |
| Janssen Pharmaceuticals, Inc | 4 | $79 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $69 |
| Indivior Inc. | 3 | $66 |
Products named: VIVITROL, REXULTI, Auvelity, CAPLYTA, ARISTADA, SPRAVATO, INGREZZA, COBENFY.
Industry payments across NC — which companies pay providers there.
